{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:05:48Z","timestamp":1756339548052,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,2,8]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Thrombotic thrombocytopenic purpura (TTP) is a type of thrombotic microangiopathy that is characterized by microangiopathic haemolytic anaemia, consumption thrombocytopenia and organ injury. It is caused by a severe deficiency of ADAMTS13, which can be either congenital or acquired. There is a plethora of things that can cause the acquired form, including medications and infections. Vaccines have also been shown to cause TTP. In the midst of the COVID-19 pandemic, with multiple new vaccines being developed and distributed to the masses, the medical community needs to be aware of adverse events associated with these new vaccines. We present a case of TTP following administration of the Moderna booster vaccine.<\/jats:p>","DOI":"10.1136\/bcr-2021-247576","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T03:59:04Z","timestamp":1666583944000},"page":"e247576","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Thrombotic thrombocytopenic purpura following administration of the Moderna booster vaccine"],"prefix":"10.1136","volume":"15","author":[{"given":"Emma","family":"Herrman","sequence":"first","affiliation":[{"name":"Internal Medicine, Beaumont Health, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bipin","family":"Ghimire","sequence":"additional","affiliation":[{"name":"Internal Medicine, Beaumont Health, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2676-9577","authenticated-orcid":false,"given":"Mohammad Muhsin","family":"Chisti","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Oakland University William Beaumont School of Medicine, Troy, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"2025082710195532000_15.3.e247576.1","unstructured":"CDC . Different COVID-19 vaccines, 2021. Available: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines.html"},{"key":"2025082710195532000_15.3.e247576.2","doi-asserted-by":"crossref","unstructured":"Lee E , Cines DB , Gernsheimer T . Thrombocytopenia following Pfizer and Moderna SARS\u2010CoV\u20102 vaccination. Am J Hematol 2021.","DOI":"10.1002\/ajh.26132"},{"key":"2025082710195532000_15.3.e247576.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840"},{"key":"2025082710195532000_15.3.e247576.4","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082710195532000_15.3.e247576.5","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082710195532000_15.3.e247576.6","first-page":"1","article-title":"Recurrence of thrombotic thrombocytopenic purpura after mRNA-1273 COVID-19 vaccine administered shortly after COVID-19","volume":"2021","author":"Karabulut","year":"2021","journal-title":"Case Rep Hematol"},{"key":"2025082710195532000_15.3.e247576.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857"},{"key":"2025082710195532000_15.3.e247576.8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MBC.0000000000000058","article-title":"Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination","volume":"25","author":"Kojima","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2025082710195532000_15.3.e247576.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05823.x"},{"key":"2025082710195532000_15.3.e247576.10","first-page":"322","article-title":"Immune thrombocytopenic purpura following influenza vaccination","volume":"8","author":"Tishler","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"2025082710195532000_15.3.e247576.11","first-page":"587","article-title":"Thrombotic thrombocytopenic purpura following influenza vaccination--a brief case report","volume":"62","author":"Ramakrishnan","year":"1998","journal-title":"Conn Med"},{"key":"2025082710195532000_15.3.e247576.12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/tme.12160","article-title":"Rabies vaccine-associated thrombotic thrombocytopenic purpura","volume":"24","author":"Kadikoylu","year":"2014","journal-title":"Transfus Med"},{"key":"2025082710195532000_15.3.e247576.13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00063-010-1107-6","article-title":"[Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination]","volume":"105","author":"Hermann","year":"2010","journal-title":"Med Klin"},{"key":"2025082710195532000_15.3.e247576.14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00277-021-04584-y","article-title":"Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine","volume":"101","author":"Ruhe","year":"2022","journal-title":"Ann Hematol"},{"key":"2025082710195532000_15.3.e247576.15","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/jth.15418","article-title":"First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination","volume":"19","author":"de Bruijn","year":"2021","journal-title":"J Thromb Haemost"},{"key":"2025082710195532000_15.3.e247576.16","doi-asserted-by":"crossref","first-page":"103145","DOI":"10.1016\/j.transci.2021.103145","article-title":"Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine","volume":"60","author":"Sissa","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"2025082710195532000_15.3.e247576.17","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/bjh.17782","article-title":"Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab","volume":"196","author":"Kirpalani","year":"2022","journal-title":"Br J Haematol"},{"key":"2025082710195532000_15.3.e247576.18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12185-021-03190-y","article-title":"Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine","volume":"114","author":"Waqar","year":"2021","journal-title":"Int J Hematol"},{"key":"2025082710195532000_15.3.e247576.19","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/jth.15420","article-title":"Acquired thrombotic thrombocytopenic purpura: a rare disease associated with BNT162b2 vaccine","volume":"19","author":"Maayan","year":"2021","journal-title":"J Thromb Haemost"},{"key":"2025082710195532000_15.3.e247576.20","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.219","article-title":"Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine","author":"Al-Ahmad","year":"2021","journal-title":"EJHaem"},{"key":"2025082710195532000_15.3.e247576.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-884700"},{"key":"2025082710195532000_15.3.e247576.22","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-111942","article-title":"Do immune-mediated TTP patients presenting with no detectable ADAMTS13 antibody represent a unique clinical phenotype?","volume":"132","author":"Shaw","year":"2018","journal-title":"Blood"},{"key":"2025082710195532000_15.3.e247576.23","article-title":"The impact of detectable ADAMTS13 inhibitor on the clinical presentation and outcome of patients with immune thrombotic thrombocytopenic purpura (iTTP): analysis using the United States thrombotic microangiopathy (USTMA) clinical Registry","volume":"130","author":"Sridharan","year":"2017","journal-title":"Blood"},{"key":"2025082710195532000_15.3.e247576.24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.transci.2018.02.003","article-title":"Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura","volume":"57","author":"Demirsoy","year":"2018","journal-title":"Transfus Apher Sci"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-247576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:20:07Z","timestamp":1756315207000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-247576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,24]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bcr-2021-247576"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-247576","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}